Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$7.85M Sell
109,299
-12,877
-11% -$1.21M 0.05% 283
2026
Q1
$14.4M Buy
122,176
+8,501
+7% +$1.05M 0.1% 163
2025
Q4
$14.3M Sell
113,675
-10,798
-9% -$1.41M 0.11% 147
2025
Q3
$18.2M Buy
124,473
+15,768
+15% +$2.38M 0.14% 110
2025
Q2
$17M Buy
108,705
+1,174
+1% +$186K 0.14% 119
2025
Q1
$17.7M Buy
107,531
+592
+0.6% +$98.4K 0.17% 100
2024
Q4
$17.4M Buy
106,939
+2,814
+3% +$503K 0.16% 100
2024
Q3
$20.3M Buy
104,125
+6,579
+7% +$1.21M 0.2% 84
2024
Q2
$16.9M Sell
97,546
-7,605
-7% -$1.27M 0.17% 94
2024
Q1
$17.8M Buy
105,151
+55
+0.1% +$10.3K 0.19% 92
2023
Q4
$20.7M Sell
105,096
-538
-0.5% -$95.2K 0.25% 69
2023
Q3
$18.4M Buy
105,634
+692
+0.7% +$126K 0.25% 67
2023
Q2
$18.1M Buy
104,942
+463
+0.4% +$80K 0.24% 69
2023
Q1
$17.4M Buy
104,479
+1,939
+2% +$318K 0.25% 74
2022
Q4
$15M Buy
102,540
+8,067
+9% +$1.19M 0.24% 79
2022
Q3
$14M Sell
94,473
-663
-0.7% -$111K 0.27% 68
2022
Q2
$16.4M Sell
95,136
-7,345
-7% -$1.27M 0.33% 53
2022
Q1
$19.3M Buy
102,481
+987
+1% +$195K 0.32% 61
2021
Q4
$24.8M Buy
101,494
+6,484
+7% +$1.42M 0.39% 42
2021
Q3
$18.4M Sell
95,010
-2,243
-2% -$453K 0.35% 51
2021
Q2
$18.1M Buy
97,253
+32,141
+49% +$5.58M 0.33% 57
2021
Q1
$10.3M Sell
65,112
-198
-0.3% -$31.4K 0.22% 87
2020
Q4
$10.8M Buy
65,310
+1,329
+2% +$216K 0.24% 75
2020
Q3
$10.6M Buy
63,981
+180
+0.3% +$27.7K 0.26% 71
2020
Q2
$8.74M Buy
+63,801
New +$8.33M 0.23% 96

Other funds holding ZTS

Xponance's ZTS Position: Q2 2026 in Review

Xponance reduced its Zoetis (ZTS) stake by 11% in Q2 2026, selling an estimated $1.21M and leaving 109,299 shares worth $7.85M. The position accounts for 0.05% of the portfolio, ranked #283.

Xponance first reported a position in ZTS in Q2 2020 and has held it in 25 quarters since. The position peaked at $24.8M in Q4 2021. 1,427 funds tracked by Wall St. Rank hold ZTS as of Q2 2026.

  • Xponance held 109,299 shares of Zoetis worth $7.85M as of Q2 2026.
  • Xponance sold 12,877 Zoetis shares in Q2 2026, an estimated $1.21M.
  • Zoetis made up 0.05% of Xponance's portfolio in Q2 2026, its #283 holding.
  • Xponance first reported a position in Zoetis in Q2 2020 and has held it in 25 quarters since.
  • Xponance's Zoetis position peaked at $24.8M in Q4 2021.
  • 1,427 funds tracked by Wall St. Rank held Zoetis as of Q2 2026.

Based on Xponance's 13F filing for Q2 2026, filed 10 Aug 2026.